AbbVie Non-GAAP EPS of $2.46 beats by $0.06, revenue of $13.34B beats by $420M

AbbVie press release ( NYSE: ABBV ): Q1 Non-GAAP EPS of $2.46 beats by $0.06 .

Revenue of $13.34B (+8.4% Y/Y) beats by $420M .



First-Quarter Global Net Revenues from the Neuroscience Portfolio Were $2.282 Billion, an Increase of 16.1 Percent on a Reported Basis, or 17.

0 Percent.